IKT

Inhibikase Therapeutics, Inc. SEC filings

Every EDGAR filing for Inhibikase Therapeutics, Inc. (IKT), newest first, with AI summaries and stories.

Ticker
IKT
CIK
1750149
Latest filing
Sep 8

Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 16 (deadline Nov 16) · usually files the same day as earnings

Watch in the app Get the app

Get an email when Inhibikase Therapeutics, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  3. ROUTINESCHEDULE 13G/AInhibikase Therapeutics, Inc.IKT

    2 13G filings

    Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    PERCEPTIVE ADVISORS LLC, filed by

  9. ROUTINE4Inhibikase Therapeutics, Inc.IKT

    2 insider filings

    RA Capital Healthcare Fund LP, insider filing for IKT

    Show all 2
    • 4Insider filing for IKT
    • 4Insider filing for IKT

    RA Capital Healthcare Fund LP, reporting · RA CAPITAL MANAGEMENT, L.P., reporting · +2 more

  16. ROUTINE4Inhibikase Therapeutics, Inc.IKT

    6 insider filings

    Dennis N Berman, insider filing for IKT

    Show all 6
    • 4Insider filing for IKT
    • 4Insider filing for IKT
    • 4Insider filing for IKT
    • 4Insider filing for IKT
    • 4Insider filing for IKT
    • 4Insider filing for IKT

    Dennis N Berman, reporting

  19. ROUTINESCHEDULE 13G/AInhibikase Therapeutics, Inc.IKT

    3 13G filings

    Ownership stake disclosure by Trails Edge Capital Partners, LP (amended)

    Show all 3
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    Trails Edge Capital Partners, LP, filed by

  30. ROUTINE4Inhibikase Therapeutics, Inc.IKT

    3 insider filings

    Vincent Aurentz, insider filing for IKT

    Show all 3
    • 4Insider filing for IKT
    • 4Insider filing for IKT
    • 4Insider filing for IKT

    Vincent Aurentz, reporting

  32. ROUTINESCHEDULE 13G/AInhibikase Therapeutics, Inc.IKT

    2 13G filings

    Ownership stake disclosure by Fairmount Funds Management LLC (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    Fairmount Funds Management LLC, filed by

  35. ROUTINE4Inhibikase Therapeutics, Inc.IKT

    3 insider filings

    Mark T Iwicki, insider filing for IKT

    Show all 3
    • 4Insider filing for IKT
    • 4Insider filing for IKT
    • 4Insider filing for IKT

    Mark T Iwicki, reporting

Older filings on EDGAR